Template:ADA guidelines: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) No edit summary |
Tarek Nafee (talk | contribs) No edit summary |
||
| Line 58: | Line 58: | ||
! | ! | ||
'''Foundations of Care and Comprehensive Medical Evaluation''' | '''Foundations of Care and Comprehensive Medical Evaluation''' | ||
:[[Nutritional Therapy]] | :[[Nutritional Therapy in Diabetes|Nutritional Therapy]] | ||
:[[Other Lifestyle Recommendations]] | :[[Lifestyle Recommendations in Diabetes|Other Lifestyle Recommendations]] | ||
|- | |- | ||
! | ! | ||
| Line 71: | Line 71: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Glycemic Targets]] | [[Glycemic Targets in Diabetes|Glycemic Targets]] | ||
|- | |- | ||
! | ! | ||
| Line 83: | Line 83: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Approaches to Glycemic Treatment]] | [[Approaches to Glycemic Treatment in Diabetes|Approaches to Glycemic Treatment]] | ||
|- | |- | ||
! | ! | ||
| Line 90: | Line 90: | ||
! | ! | ||
'''Cardiovascular Disease and Risk Management''' | '''Cardiovascular Disease and Risk Management''' | ||
:[[Hypertension and Blood Pressure Control in Diabetics]] | :[[Hypertension and Blood Pressure Control in Diabetics|Hypertension and Blood Pressure Control]] | ||
:[[Lipid Management in Diabetics]] | :[[Lipid Management in Diabetics|Lipid Management]] | ||
:[[Antiplatelet agents in Diabetics]] | :[[Antiplatelet agents in Diabetics|Antiplatelet Agents]] | ||
:[[Coronary heart disease in Diabetics]] | :[[Coronary heart disease in Diabetics|Coronary Heart Disease]] | ||
|- | |- | ||
! | ! | ||
| Line 100: | Line 100: | ||
! | ! | ||
[[Microvascular Complications and Foot Care]] | [[Microvascular Complications and Foot Care]] | ||
:[[Diabetic Kidney Disease Recommendations]] | :[[Diabetic Kidney Disease Recommendations|Diabetic Kidney Disease]] | ||
:[[Diabetic Retinopathy Recommendations]] | :[[Diabetic Retinopathy Recommendations|Diabetic Retinopathy]] | ||
:[[Diabetic Neuropathy Recommendations]] | :[[Diabetic Neuropathy Recommendations|Diabetic Neuropathy]] | ||
:[[Diabetic Foot care Recommendations]] | :[[Diabetic Foot care Recommendations|Diabetic Footcare]] | ||
|- | |- | ||
! | ! | ||
Revision as of 16:12, 6 December 2016
|
ADA Guidelines |
|
Types of Diabetes Mellitus |
|---|
|
ADA Standard of Medical Care in Diabetes |
|
Foundations of Care and Comprehensive Medical Evaluation |
|
Cardiovascular Disease and Risk Management |